glp-1-based therapy Oral Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 Medications Show Promise as

HPLC + mass spec, Janoshik

CoronationBio has licensed the intellectual property of ODN derivatives for the treatment of obesity and cardio-metabolic diseases and is continuing to work with me and other authors of this manuscript to translate drug candidates into the clinic

Hepatol Res 45(3):269278 Errafii K, Khalifa O, Al-Akl NS, Arredouani A (2022) Comparative transcriptome analysis reveals that Exendin-4 improves steatosis in HepG2 cells by modulating signaling pathways related to lipid metabolism

Walk daily, even lightly

10.2147/DMSO.S450695 37

Lin XY, Li HB, Juhasz AL, Jiao DD, Zhou L, Xue RY, Tang Y, Luo X, Zhou D, Ma LQ (2025b) Lower cadmium bioavailability and toxicity in Japonica rice than in Indica rice: mechanisms and health implications